Introduction

60
Alcoholic liver disease (ALD) is a result of chronic consumption of excessive alcohol.
61
The clinical spectrum of ALD includes alcoholic fatty liver, alcoholic hepatitis (AH), alcoholic 62 cirrhosis and hepatocellular carcinoma (12) . Alcoholic fatty liver is considered a reversible and 63 non-progressive entity. AH, the most severe form of ALD, is associated with high mortality; up 64 to 40 % of severe AH patients die within 6 months (22). Although AH shows such a high 65 mortality, treatment of AH is still largely dependent on corticosteroid for controlling 66 inflammation, which has not been improved in the past 40 years (14) . Survived AH patients may 67 either have co-existing cirrhosis or it may progress to alcoholic liver cirrhosis and 3-10% of 68 cirrhotic patients ultimately develop hepatocellular carcinoma (HCC).
69
It has been shown that ethanol itself and its metabolite-induced cytotoxicity are directly contributing to the pathogenesis of ALD (15, 17) . Indeed, mice deficient in TLR4, CD14 and 78 LBP are protective against alcohol-induced liver injury (15, 17, 39, 43) . Consistently, gut 79 sterilization with oral administration of non-absorbable antibiotics reduces plasma LPS levels 80 and alcohol-induced liver inflammation and injury in mice (1). Although TLR4 activates both
81
MyD88 and TRIF-dependent intracellular signaling pathways, the TRIF-IRF3 axis appears to be 82 5 more critical than the MyD88-dependent pathway for the development of ALD (15, 29) .
83
TLR2 and TLR9 recognize the surface structures of gram-positive bacteria (38) and the
84
CpG containing DNA derived from virus and bacteria (2), respectively. We have previously 85 reported that TLR2 and TLR9 signaling contribute to the development of non-alcoholic 86 steatohepatitis (NASH) through activation of inflammasome and IL-1β signaling (27, 28) . Since 87 the common signaling pathways may be activated in both ALD and NASH, it is suggested that 88 chronic alcohol consumption increases the hepatic and systemic levels of ligands for TLR2 and 89 TLR9, which activate hepatic TLR2 and TLR9 signaling, resulting in induction of ALD. Indeed, 90 serum levels of bacterial DNA are increased in patients with AH (5).
91
Neutrophil recruitment is strongly associated with the hepatocyte death in human AH In the present study, we investigated the functions of TLR2 and TLR9 signaling in 106 hepatic neutrophil infiltration in the chronic-binge ethanol-feeding model, and examined the 107 responsible cell types for the production of neutrophil chemoattractant, CXCL1. We also tested 
Materials and Methods
113
Study Design
114
C57BL/6 wild type (WT) and TLR2-deficient mice were purchased from Jackson 115 Laboratories (Bar Harbor, ME) and TLR9-deficient mice were originally generated by Dr. Akira
116
(Osaka University, Suita, Japan). All mice including WT mice were bred in the University of 117 California San Diego vivarium. TLR2-deficient and TLR9-deficient mice were back-crossed at 118 least 10 generations onto the C57BL/6 background and displayed a similar hepatic phenotype as
119
WT mice under standard laboratory chow. Female mice of each genotype were divided into two 120 groups at 8-10 weeks of age: control diet and Lieber-DeCarli diet (Bio-Serv, Frenchtown, NJ) as 121 followed by previous study (6). Each experiment included 6-8 mice/group and the data were the 122 averages from at least two independent experiments.
123
For induction of mouse ALD, we followed the protocol of chronic plus binge ethanol 124 feeding model as previously described (6) with slight modifications. Briefly, mice were fed with 125 a control liquid diet ad libitum for the first 5 days as an acclimatization step and subsequently fed 126 with a Lieber-DeCarli diet (Bio-Serv, Frenchtown, NJ) containing 6.3% ethanol (vol/vol) for 10 127 days. In the morning on the 11th day, mice were subjected to receive single dose of binge ethanol 128 (5g/kg of BW) and sacrificed 9 hours after the ethanol binge. 
TG extraction and Measurement
180
Hepatic triglycerides (TG) were extracted as described (27 Cxcl1, Cxcl2, Cxcl5 and Ccl2, was markedly increased 6-15 fold in ethanol-treated WT livers 218 whereas the expression of these chemokines were reduced in ethanol-treated TLR2 and TLR9-219 deficient mice (Fig. 1D ). Increased hepatic protein expression of CXCL1 and serum level of 220 CXCL1 in WT mice were significantly suppressed in TLR2 and TLR9-deficient mice (Fig. 1E ).
221
Accordingly, neutrophil infiltration was also suppressed in TLR2 and TLR9-deficient mice as 222 assessed by the expression of Ly-6G (Fig. 1F) . These results indicate that TLR2 and TLR9 223 signaling contribute to liver damage, production of neutrophil-recruiting chemokines and 224 neutrophil infiltration in the chronic-binge ethanol-feeding model. KCs from ethanol-fed mice showed reduced expression of Cxcl1 compared with KCs from pair-248 fed mice (Fig. 3A) , which supports our data showing that KCs have minor roles in neutrophil 249 infiltration induced by chronic-binge ethanol treatment (Fig. 2) . To further investigate the 250 mechanism underlying TLR2 and TLR9-dependent CXCL1 production, we treated primary 251 cultured hepatocytes with a synthetic TLR2 ligand (Pam3CSK4) and TLR9 ligand (ODN1668).
252
The ODN1668 alone could not induce Cxcl1 expression, but pretreatment with Pam3CSK4 253 enabled primary hepatocytes to produce CXCL1 in response to ODN1668 (Fig. 3B) . Notably, the 254 synergistic effect induced by TLR2 and TLR9 ligands was observed only in hepatocytes, but not 255 in HSCs (Fig. 3C ). These results indicate that TLR2 and TLR9 signaling has capacity to induce 256 CXCL1 production in hepatocytes and HSCs. Since CXCL1 is a potent neutrophil-recruiting chemokines, we examined the correlation 260 between liver injury and CXCL1 levels in mice with or without chronic-binge ethanol feeding.
261
As illustrated in Fig. 4A , serum ALT levels positively correlate with serum CXCL1 levels in Fig. 4C and 4D ). These results suggested that inhibition of the CXCL1-CXCR2 axis 
274
Given that both TLR2 and TLR9-deficient mice were protected against alcohol insults 275 ( Fig. 1-4 ), MyD88, a common adaptor molecule for IL-1 receptor and all TLRs, except for TLR3, 276 may play a crucial role in liver injury induced by chronic-binge ethanol-treatment. To test the 277 therapeutic potential of MyD88 inhibition, we treated mice with a MyD88 inhibitory peptide.
278
Inhibiting MyD88 significantly suppressed liver injury (Fig. 5A ) and serum CXCL1 levels in the 279 chronic-binge ethanol-treated mice (Fig. 5B ). These results were further supported by the 280 reduction of CXCL1 and neutrophil markers in the liver ( Fig. 5C and 5D ). The MyD88 281 inhibition also reduced the hepatic Il1b expression, but not Il6 and Tnf, which resembles the 282 results from TLR2 and 9-deficient mice after the chronic-binge ethanol-treatment (Fig.1C) .
283
These results demonstrated that the MyD88 blockade could prevent liver damage through the 284 suppression of CXCL1, IL-1β production and neutrophil recruitment in acute-on-chronic ethanol 285 feeding model. The present study clearly demonstrated that activation of TLR2 and TLR9 signaling 296 contributes to hepatic production of CXCL1, recruiting neutrophils into the liver in the chronic- 
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The previous studies reported that chronic alcohol-induced liver damage and give them further directional cue for migration and infiltration (11, 26 In conclusion, TLR2 and TLR9 promote CXCL1 production in hepatocytes and HSCs, are presented as means ± SEM per group. **p < 0.01, ***p < 0.001; n.s., not significant.
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Original magnification, ×200 (F4/80 and Ly-6G). 
591
Data are presented as means ± SEM per group. *p < 0.05, **p < 0.01; n.s., not significant. 
